Dapsone‐ and nitroso dapsone‐specific activation of T cells from hypersensitive patients expressing the risk allele HLA‐B*13:01-Reference-Cited by-同舟云学术

Dapsone‐ and nitroso dapsone‐specific activation of T cells from hypersensitive patients expressing the risk allele HLA‐B*13:01

Published:2019-04-15 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Zhao Qing¹²³,Alhilali Khetam¹,Alzahrani Abdulaziz¹⁴⁵,Almutairi Mubarak¹,Amjad Juwaria¹,Liu Hong²³,Sun Yonghu²³,Sun Lele²³,Zhang Huimin²³,Meng Xiaoli¹,Gibson Andrew¹,Ogese Monday O.¹⁶,Kevin Park B.¹,Liu Jianjun⁷,Ostrov David A.⁸,Zhang Furen²³,Naisbitt Dean J.¹^ORCID

Affiliation:

1. MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology The University of Liverpool Liverpool UK

2. Department of Dermatology, Shandong Provincial Hospital for Skin Disease Shandong University Jinan China

3. Shandong Provincial Institute of Dermatology and Venereology Shandong Academy of Medical Sciences Jinan China

4. Al Baha University, Prince Mohammad Bin Saud Al Bahah Saudi Arabia

5. Pharmacology Department, College of Clinical Pharmacy AlBaha University Al Baha Saudi Arabia

6. Pathological Sciences, drug Safety and Metabolism, IMED Biotech Unit AstraZeneca Cambridge UK

7. Human Genetics Genome Institute of Singapore, A*STAR Singapore Singapore

8. Department of Pathology, Immunology and Laboratory Medicine College of Medicine University of Florida Gainesville Florida

Funder

Medical Research Council

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.13769

Reference44 articles.

1. HLAs: key regulators of T‐cell‐mediated drug hypersensitivity;Redwood AJ;HLA,2018

2. Coupling genotyping and computational modeling in prediction of anti‐epileptic drugs that cause stevens johnson syndrome and toxic epidermal necrolysis for carrier of HLA‐B*15:02;Teh LK;J Pharm Pharm Sci,2016

3. Adverse drug reactions triggered by the common HLA‐B*57:01 variant: a molecular docking study;Driessche G;J Cheminform,2017

4. HLA‐B*5701 screening for hypersensitivity to abacavir;Mallal S;N Engl J Med,2008

5. HLA‐B*5701 genotype is a major determinant of drug‐induced liver injury due to flucloxacillin;Daly AK;Nat Genet,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-B*35:01-mediated activation of emodin-specific T cells contributes to Polygonum multiflorum thunb. -induced liver injury in mice;Journal of Ethnopharmacology;2024-11

2. Clues of HLAs, metabolic SNPs, and epigenetic factors in T cell-mediated drug hypersensitivity reactions;Heliyon;2024-07

3. Glycolysis: An early marker for vancomycin‐specific T‐cell activation;Clinical & Experimental Allergy;2024-01

4. Advances in the pathogenic, genetic and immunological studies of leprosy;hLife;2024-01

5. Overview and Current Advances in Dapsone Hypersensitivity Syndrome;Current Allergy and Asthma Reports;2023-10-07